Correlation Between Plasma Amino Acid Profiles and the Various Stages of Hepatitis B Infection

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2012 Feb 2

PMID 22294098

Citations 9

Authors

J Yang

J He

H Cao

X Zhao

S Fu

H Lu

Y Chen

X Pan

L Li

Affiliations

Soon will be listed here.

Abstract

The amino acid metabolism in patients with hepatitis B virus (HBV) infection is significantly changed. In this study, we analyzed the relationship between the amino acid profiles and varying clinical stages of HBV infection, and investigated their significance. The plasma amino acid concentrations in 115 patients with HBV infection and 32 healthy donors were detected and analyzed, and the main indicators of liver function were measured. Correlation analysis was performed between the amino acid profiles (Fischer's ratio, branched-chain amino acid to tyrosine ratio [BTR]) and the key indicators of liver function in patients with HBV infection. Fisher's ratio and the BTR of patients with HBV infection was found to differ from that of the healthy controls, and was also found to significantly correlate with the stage of HBV infection. Changes in the BTR were closely related to the level of key indicators of liver function, and a significant relationship was detected between the Fischer's ratio and the BTR (r=0.928, p<0.001). These results suggest that Fischer's ratio and the BTR can indirectly reflect the degree of liver cell injury. Determining and tracking the plasma amino acid profiles could, therefore, be used for the diagnosis, treatment selection, and prognosis of patients with varying stages of HBV infection.

Citing Articles

Serum metabolic signatures of schizophrenia patients complicated with hepatitis B virus infection: A H NMR-based metabolomics study.

Lin C, Hu Q, Dong J, Wei Z, Li J, Chen Z Front Psychiatry. 2023; 13:998709.

PMID: 36620683 PMC: 9810819. DOI: 10.3389/fpsyt.2022.998709.

Serum protein concentration and amino acid profile of HIV/HBV co-infected subjects on HAART in Plateau State, Nigeria.

Igwe C, Ewuga E, Ujowundu C, Onyeocha I, Onwuliri V Afr Health Sci. 2022; 22(1):418-430.

PMID: 36032489 PMC: 9382465. DOI: 10.4314/ahs.v22i1.51.

The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology.

Dimou A, Tsimihodimos V, Bairaktari E Int J Mol Sci. 2022; 23(7).

PMID: 35409380 PMC: 8999875. DOI: 10.3390/ijms23074022.

Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy.

Zeng Y, Qin L, Wei W, Cai H, Yu X, Zhang W Sci Rep. 2021; 11(1):3253.

PMID: 33547384 PMC: 7864979. DOI: 10.1038/s41598-021-82939-1.

Comparative proteomic analysis of maize (Zea mays L.) seedlings under rice black-streaked dwarf virus infection.

Yue R, Lu C, Han X, Guo S, Yan S, Liu L BMC Plant Biol. 2018; 18(1):191.

PMID: 30208842 PMC: 6136180. DOI: 10.1186/s12870-018-1419-x.

References

Zhang Q, Takahashi M, Noguchi Y, Sugimoto T, Kimura T, Okumura A . Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection. Hepatol Res. 2006; 34(3):170-7. DOI: 10.1016/j.hepres.2005.12.006. View

Tessari P, Kiwanuka E, Vettore M, Barazzoni R, Zanetti M, Cecchet D . Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion. Am J Physiol Gastrointest Liver Physiol. 2008; 295(3):G598-604. DOI: 10.1152/ajpgi.00355.2007. View

Ninomiya T, Yoon S, Sugano M, Kumon Y, Seo Y, Shimizu K . Improvement of molar ratio of branched-chain amino acids to tyrosine (BTR) associated with liver fibrosis in chronic hepatitis C patients treated with interferon-alpha. Dig Dis Sci. 1999; 44(5):1027-33. DOI: 10.1023/a:1026629202076. View

Nijveldt R, Wiezer M, Meijer C, Prins H, Statius Muller M, Gouma D . Major liver resection results in a changed plasma amino acid pattern as reflected by a decreased Fischer ratio which improves by bactericidal/permeability increasing protein. Liver. 2001; 21(1):56-63. DOI: 10.1034/j.1600-0676.2001.210109.x. View

Cynober L . Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002; 18(9):761-6. DOI: 10.1016/s0899-9007(02)00780-3. View

Xu X, Lu M, Tan D . Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005; 11(1):52-6. DOI: 10.1111/j.1469-0691.2004.01029.x. View

Ayonrinde O, Olynyk J . PAHA model: an alternative non-invasive predictor of liver cirrhosis in patients with chronic hepatitis B infection. J Gastroenterol Hepatol. 2010; 25(1):3-4. DOI: 10.1111/j.1440-1746.2009.06041.x. View

Nakamura T, Mori M, Yoshida T, Murakami N, Kato T, SUGIHARA J . [Enzymatic determination of a molar ratio of free branched-chain amino acids to tyrosine (BTR) and its clinical significance in plasma of patients with various liver diseases]. Rinsho Byori. 1989; 37(8):911-7. View

Holecek M . Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition. 2010; 26(5):482-90. DOI: 10.1016/j.nut.2009.06.027. View

10.

Ter Borg P, Fekkes D, Vrolijk J, van Buuren H . The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis. BMC Gastroenterol. 2005; 5:11. PMC: 1079813. DOI: 10.1186/1471-230X-5-11. View

11.

Kano T, Nagaki M, Takahashi T, Ohnishi H, Saitoh K, Kimura K . Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index. Gastroenterol Jpn. 1991; 26(3):344-9. DOI: 10.1007/BF02781923. View

12.

Kaito M, Nakagawa N, Fujita N, Ikoma J, Gabazza E, Watanabe S . Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease. J Clin Lab Anal. 1999; 13(1):31-4. PMC: 6808106. View

13.

Noguchi Y, Zhang Q, Sugimoto T, Furuhata Y, Sakai R, Mori M . Network analysis of plasma and tissue amino acids and the generation of an amino index for potential diagnostic use. Am J Clin Nutr. 2006; 83(2):513S-519S. DOI: 10.1093/ajcn/83.2.513S. View

14.

Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M . Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun. 2003; 313(2):405-9. DOI: 10.1016/j.bbrc.2003.07.016. View

15.

James J, Ziparo V, Jeppsson B, Fischer J . Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979; 2(8146):772-5. DOI: 10.1016/s0140-6736(79)92119-6. View

16.

Plauth M . [Branched chain amino acids as oral supplements in liver cirrhosis]. Z Gastroenterol. 2006; 44(2):207-8. DOI: 10.1055/s-2005-858949. View

17.

Doi J, Shiraishi K, Haida M, Matsuzaki S . Abnormality of energy metabolism in the skeletal muscle of patients with liver cirrhosis and changes under administration of glucose and branched-chain amino acids. Tokai J Exp Clin Med. 2005; 29(4):191-8. View

18.

Dejong C, van de Poll M, Soeters P, Jalan R, Olde Damink S . Aromatic amino acid metabolism during liver failure. J Nutr. 2007; 137(6 Suppl 1):1579S-1585S. DOI: 10.1093/jn/137.6.1579S. View

19.

Roth E, Druml W . Plasma amino acid imbalance: dangerous in chronic diseases?. Curr Opin Clin Nutr Metab Care. 2010; 14(1):67-74. DOI: 10.1097/MCO.0b013e328341368c. View

20.

Tom A, Nair K . Assessment of branched-chain amino Acid status and potential for biomarkers. J Nutr. 2005; 136(1 Suppl):324S-30S. DOI: 10.1093/jn/136.1.324S. View